What are the most common ultrasonographic findings in a fetus with congenital syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ultrasonographic Findings in Fetal Congenital Syphilis

The most common ultrasonographic finding in a fetus affected by congenital syphilis is hepatomegaly, occurring in approximately 66-79% of cases, followed by placentomegaly (27%), elevated middle cerebral artery peak systolic velocity (33%), polyhydramnios (12%), and ascites (10%). 1, 2, 3

Primary Sonographic Abnormalities

Hepatic and Abdominal Findings

  • Hepatomegaly is the earliest and most persistent finding, appearing before other manifestations and resolving last after maternal treatment 2, 3
  • Splenomegaly frequently accompanies hepatomegaly 4, 5
  • Ascites occurs in approximately 10-12.5% of cases and represents more severe disease 2, 3
  • Bowel abnormalities may be present 4

Placental and Amniotic Fluid Changes

  • Placentomegaly occurs in approximately 27% of cases 2
  • Polyhydramnios is present in about 12% of affected fetuses 2

Hematologic Indicators

  • Elevated middle cerebral artery peak systolic velocity (MCA-PSV) suggests fetal anemia, occurring in approximately 33% of cases 2, 6
  • This finding is particularly significant when occurring with ascites or atypical hydrops 4, 6

Less Common Findings

  • Fetal hydrops (nonimmune) represents severe disease 1, 5
  • Pericardial effusion 5
  • Intrahepatic calcifications 5
  • Fetal growth restriction 4
  • Brain abnormalities are rare and never isolated 4

Clinical Significance and Temporal Progression

The presence of hepatomegaly and hydrops indicates greater risk for fetal treatment failure and warrants consultation with obstetric specialists 1. After maternal treatment, sonographic abnormalities resolve in a predictable sequence: MCA-PSV abnormalities, ascites, and polyhydramnios resolve first, followed by placentomegaly, with hepatomegaly resolving last 2.

Critical Diagnostic Considerations

No individual sonographic sign or pattern is pathognomonic for fetal syphilis 4. When ultrasound abnormalities suggest congenital infection—particularly the combination of hepatomegaly, elevated MCA-PSV in the context of ascites or atypical hydrops, and placentomegaly—syphilis must be included in the differential diagnosis and maternal serologic testing (VDRL/TPHA) should be performed immediately 4, 6.

The presence of any sonographic abnormality significantly increases the risk of congenital syphilis at delivery (39% versus 12% when ultrasound is normal, P < .001) 2. Fetal anemia detected by MCA-PSV can be a crucial early signal, particularly when typical causes of fetal anemia have been excluded 6.

Management Implications

Fetuses with sonographic evidence of syphilis require:

  • Immediate maternal treatment with appropriate penicillin regimen 1
  • Serial ultrasound monitoring until resolution or delivery 2
  • Obstetric specialist consultation for cases with hepatomegaly and hydrops 1
  • Consideration of fetal and contraction monitoring for 24 hours after treatment initiation when beyond 20 weeks gestation with sonographic evidence of fetal infection 7
  • Awareness that treatment failure risk increases with severity of sonographic findings 3

References

Research

Progression of ultrasound findings of fetal syphilis after maternal treatment.

American journal of obstetrics and gynecology, 2014

Research

Fetal syphilis: clinical and laboratory characteristics.

Obstetrics and gynecology, 2001

Research

Fetal anemia as a signal of congenital syphilis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.